Carson William H. — SEC insider filings

SEC reporting owner CIK 1824280. 32 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers all 32 filings on record, filed 2020-09-11 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Annexon, Inc. (ANNX)Director2619 legs · 112,405 sh · $495,806—7
Decibel Therapeutics, Inc. (DBTX)Director4——8
Prevail Therapeutics Inc. (PRVL)Director2——2

Insider filings — Carson William H.

FiledFormIssuerReported transactionsSource
2026-11-204Annexon, Inc. (ANNX)Purchase (P): 34,000 @ $3.58EDGAR
2026-06-154Annexon, Inc. (ANNX)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2026-05-134Annexon, Inc. (ANNX)Purchase (P): 8,000 @ $5.78EDGAR
2026-04-144Annexon, Inc. (ANNX)Purchase (P): 8,000 @ $6.20EDGAR
2026-03-124Annexon, Inc. (ANNX)Purchase (P): 8,000 @ $5.67EDGAR
2026-01-024Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $5.02EDGAR
2025-12-034Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $4.47EDGAR
2025-10-314Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $3.17EDGAR
2025-10-024Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $3.05EDGAR
2025-09-044Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $2.09EDGAR
2025-08-014Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $2.43EDGAR
2025-07-014Annexon, Inc. (ANNX)Purchase (P): 4,115 @ $2.46EDGAR
2025-06-094Annexon, Inc. (ANNX)Grant/award (A): 55,000 (derivative) @ $0EDGAR
2024-12-044Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $5.33EDGAR
2024-10-024Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $5.97EDGAR
2024-09-044Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $5.48EDGAR
2024-08-054Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $6.24EDGAR
2024-07-024Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $5EDGAR
2024-06-074Annexon, Inc. (ANNX)Grant/award (A): 44,000 (derivative) @ $0EDGAR
2024-06-054Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $4.83EDGAR
2024-05-034Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $4.68EDGAR
2024-04-104Annexon, Inc. (ANNX)Purchase (P): 3,200 @ $6.07EDGAR
2023-09-254Decibel Therapeutics, Inc. (DBTX)Disposition to issuer (D): 5,000 · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · Disposition to issuer (D): 20,000 (derivative)EDGAR
2023-06-144Decibel Therapeutics, Inc. (DBTX)Grant/award (A): 5,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2023-06-124Annexon, Inc. (ANNX)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2022-06-214Decibel Therapeutics, Inc. (DBTX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-134Annexon, Inc. (ANNX)Grant/award (A): 24,000 (derivative) @ $0EDGAR
2021-06-044Annexon, Inc. (ANNX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2021-06-034Decibel Therapeutics, Inc. (DBTX)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-02-084Annexon, Inc. (ANNX)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-01-264Prevail Therapeutics Inc. (PRVL)Disposition to issuer (D): 34,000 (derivative) @ $0EDGAR
2020-09-114Prevail Therapeutics Inc. (PRVL)Grant/award (A): 34,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1824280 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs